secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001683168-24-000660
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharma raises $3.7M in $0.30/unit offering; appoints Amy Mahery to board
----------------------------------------------------------------------------

- Offering of 2.2M shares, 11.1M pre-funded warrants, and 26.7M Series A & B warrants at $0.30 per unit.
- Gross proceeds ~$3.7M; net proceeds to fund CNS-201 trial and working capital.
- Amy Mahery appointed independent director as of Feb 1, 2024; Andrzej Andraczke resigned.
- Warrant amendment for 3.756M existing warrants: exercise price reduced to $0.30 if shareholder approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824000660/0001683168-24-000660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824000660/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-000660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer